Latest news
The FDA Gives Accelerated Approval to Melanoma Treatment - pharmtech.compharmtech.com · Fri, 07 Aug 2026 14:55:43 GMTTudriqev: US FDA Approves Replimune's Skin Cancer Drug After Rejecting It Twice - Health and MeHealth and Me · Fri, 07 Aug 2026 12:34:03 GMTFDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 20:45:00 GMTWhy Is the Oncolytic Virus Therapy Market Expected to Reach - openPR.comopenPR.com · Thu, 06 Aug 2026 10:29:45 GMTWhy Oncolytic Virus Therapy Is Transforming Cancer Treatment Through Precision Immunotherapy, Tumor Selectivity, and Advanced Viral Engineering: Industry Analysis and Forecast - Spherical InsightsSpherical Insights · Wed, 29 Jul 2026 12:51:12 GMTGene-based immunotherapy in osteosarcoma: from oncolytic vectors to engineered immune cells - frontiersin.orgfrontiersin.org · Mon, 27 Jul 2026 16:20:39 GMT